2-nitrophenyl-egta has been researched along with 1-methyl-3-isobutylxanthine in 1 studies
Studies (2-nitrophenyl-egta) | Trials (2-nitrophenyl-egta) | Recent Studies (post-2010) (2-nitrophenyl-egta) | Studies (1-methyl-3-isobutylxanthine) | Trials (1-methyl-3-isobutylxanthine) | Recent Studies (post-2010) (1-methyl-3-isobutylxanthine) |
---|---|---|---|---|---|
57 | 0 | 8 | 5,148 | 5 | 279 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sakaba, T; Yao, L | 1 |
1 other study(ies) available for 2-nitrophenyl-egta and 1-methyl-3-isobutylxanthine
Article | Year |
---|---|
cAMP modulates intracellular Ca2+ sensitivity of fast-releasing synaptic vesicles at the calyx of Held synapse.
Topics: 1-Methyl-3-isobutylxanthine; Action Potentials; Allosteric Regulation; Animals; Calcium; Calcium Channels; Calcium Signaling; Cochlear Nucleus; Colforsin; Cyclic AMP; Egtazic Acid; Excitatory Postsynaptic Potentials; Patch-Clamp Techniques; Photolysis; Rats; Rats, Wistar; Second Messenger Systems; Synaptic Vesicles | 2010 |